Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 5Terminated 1

Sponsor Class

INDUSTRY 5OTHER 1NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Paclitaxel 489Carboplatin 435Gemcitabine 394Docetaxel 385Cisplatin 359pembrolizumab 343Bevacizumab 335Nivolumab 261Pemetrexed 242Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × ABT751 × Clear all
NCT00297089 2013-01-31

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

AbbVie

Phase 1/2 Completed
165 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00063102 2007-11-29

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Abbott

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

NCT00073112 2007-11-29

A Study of ABT-751 in Patients With Renal Cell Cancer

Abbott

Phase 2 Completed
60 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00073138 2007-11-29

A Study of ABT-751 in Patients With Colorectal Cancer

Abbott

Phase 2 Completed
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00073151 2007-11-29

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Abbott

Phase 2 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡